Galectin Therapeutics Inc.
$4.17
+0.22 (+5.57%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +37.6%
- 3 Months
- +72.3%
- YTD
- +0.2%
- 1 Year
- -2.6%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 94.5%
- Largest decline max drawdown, since Aug 2025
- -68.0%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.45
Own GALT?
See how GALT contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.